Dr Charlotte Stenson Dr Felicity Dewhurst Dr Wendy Osborne Dr Tobias Menne Dr Rachel Stocker et al. | A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: Recommendations for service development and implications for palliative care teams | 2023 |
|
Dr Sarah Fordham Dr Wei-Yu Lin Dr Helen Blair Dr Claire Elstob Dr Hayden Bell et al. | Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia | 2023 |
|
Dr Tobias Menne Dr Wendy Osborne
| CAR T in patients with large B-cell lymphoma not fit for autologous transplant | 2023 |
|
Dr Tobias Menne
| Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma | 2023 |
|
Dr Sarah Fordham Dr Helen Blair Dr Claire Elstob Professor Ruth Plummer Dr Yvette Drew et al. | Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase | 2018 |
|
Bijal Patel Dr Tobias Menne
| Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: Toxicity data from the UKALL14 trial | 2017 |
|
Dr Tobias Menne
| Preliminary results of a phase ii study of Brentuximab vedotin using a response adapted design in the first line treatment of patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity (BREVITY) | 2016 |
|
Dr Tobias Menne
| Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation for Adult De Novo Acute Lymphoblastic Leukemia: A Proespective Study from the UKALL14 Trial (ISRCTN 66541317) | 2016 |
|
Professor Anthony Moorman Dr Tobias Menne
| CD20 Expression in Adults with Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) from UKALL14, its Regulation by Dexamethasone and Rituximab Induced Cytotoxicity | 2014 |
|
Dr Samuel Moses Professor Stephen O'Brien Dr Tobias Menne Dr Jonathan Wallis
| Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia | 2014 |
|
Dr Samuel Moses Professor Stephen O'Brien Dr Tobias Menne Dr Jonathan Wallis
| Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia | 2012 |
|